We assume no obligation to update any forward-looking statement.Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales.
On March 9, 2016, the Board of Directors of the Company authorized the repurchase of up to $10,000 of the Company’s outstanding shares of common stock under a stock repurchase program.
The transactions effectuated to date occurred in open market purchases.
The Company evaluates certain factors including the customer’s ability to pay (or credit risk).
Early application will be permitted for all organizations.
Sales returns and allowances are estimated based on historical experience.
Options may be granted to employees, officers, non-employee directors and other service providers and may be granted upon such terms as the Compensation Committee of the Board of Directors determines in their sole discretion.
The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.
As scheduled delivery dates are within one year, revenue allocated to future shipments of partially completed contracts are not disclosed.During 2018-Q2, revenue declined across all regions except China and Latin America.
In addition to capital expenditures, we may use cash in the near future for selective infusions of technology, sales and marketing, infrastructure, and other investments to fuel our growth.
In addition, a discrete tax expense of $64 thousand is primarily attributable to changes in income tax reserves related to an income tax audit in Hong Kong.
While focusing on strategic innovation that we believe will strengthen our competitive position, and accelerated product development, we have also planned and initiated a company-wide cost cutting programs.
When we capitalize patent defense costs we amortize the costs over the remaining estimated useful life of the patent, which is 15 to 17 years.
Our revenue decreased by $3.3 million, or 32%, to $7.0 million in 2018-Q2 compared to $10.3 million in 2017-Q2.
When we capitalize patent defense costs we amortize the costs over the remaining estimated useful life of the patent, which is 15 to 17 years.
We assume no obligation to update any forward-looking statement.The material weakness will be fully remediated when, in the opinion of management, the control processes have been operating for a sufficient period of time to provide reasonable assurance as to their effectiveness.Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.